These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Egg hypersensitivity and measles-mumps-rubella vaccine administration. Beck SA; Williams LW; Shirrell MA; Burks AW Pediatrics; 1991 Nov; 88(5):913-7. PubMed ID: 1945631 [TBL] [Abstract][Full Text] [Related]
6. [Acute gastroenteritis and acute obstructive bronchitis after mumps-measles-rubella (MMR) preventive vaccination? The Pediatric Vaccination Counseling Service]. Wiersbitzky S; Bruns R; Wiersbitzky H Kinderarztl Prax; 1992 Dec; 60(9-10):302-3. PubMed ID: 1289650 [No Abstract] [Full Text] [Related]
7. [Encephalitis, meningitis serosa and parotitis after MMR preventive vaccination? The Pediatric Vaccination Counseling Unit]. Wiersbitzky S; Bruns R; Peters A; Mentel R Kinderarztl Prax; 1992 Oct; 60(7):203-5. PubMed ID: 1359186 [No Abstract] [Full Text] [Related]
8. Effects and side effects of a new trivalent combined measles-mumps-rubella (MMR) vaccine. Isozaki M; Kuno-Sakai H; Hoshi N; Takesue R; Takakura I; Kimura M; Hikino M; Mitsuda M Tokai J Exp Clin Med; 1982 Sep; 7(5):547-50. PubMed ID: 7182947 [TBL] [Abstract][Full Text] [Related]
9. [Drug clinics. Drug of the month. A new measles-rubella-mumps vaccine (Priorix)]. Senterre J Rev Med Liege; 1999 Feb; 54(2):122-4. PubMed ID: 10221066 [TBL] [Abstract][Full Text] [Related]
10. Unilateral total deafness as a complication of the measles-mumps-rubella vaccination. Nabe-Nielsen J; Walter B Scand Audiol Suppl; 1988; 30():69-70. PubMed ID: 3227284 [TBL] [Abstract][Full Text] [Related]
12. The measles-mumps-rubella vaccination program in Finland. Lerman SJ N Engl J Med; 1995 Apr; 332(16):1103. PubMed ID: 7898541 [No Abstract] [Full Text] [Related]
13. [Certain problems with limits of immunity against measles, mumps and rubella]. Magdzik W Przegl Epidemiol; 1993; 47(1-2):47-53. PubMed ID: 8351387 [TBL] [Abstract][Full Text] [Related]
14. Measles, mumps, and rubella--vaccine use and strategies for elimination of measles, rubella, and congenital rubella syndrome and control of mumps: recommendations of the Advisory Committee on Immunization Practices (ACIP). Watson JC; Hadler SC; Dykewicz CA; Reef S; Phillips L MMWR Recomm Rep; 1998 May; 47(RR-8):1-57. PubMed ID: 9639369 [TBL] [Abstract][Full Text] [Related]
15. [Response to Dr. Gaillet's letter: An open question to those responsible for the MMR vaccination program]. Suter S Rev Med Suisse Romande; 1988 Nov; 108(11):1001-2. PubMed ID: 3206041 [No Abstract] [Full Text] [Related]
16. Measles, mumps, rubella vaccine administration in egg-sensitive children: systemic reactions during vaccine desensitization. Trotter AC; Stone BD; Laszlo DJ; Georgitis JW Ann Allergy; 1994 Jan; 72(1):25-8. PubMed ID: 8291745 [TBL] [Abstract][Full Text] [Related]
17. [Exanthema with high fever and cerebral seizure susceptibility after mumps-measles-rubella (MMR) preventive vaccination?]. Wiersbitzky S; Bruns R; Mentel R Kinderarztl Prax; 1993 Aug; 61(6):227-8. PubMed ID: 8105135 [No Abstract] [Full Text] [Related]
19. Safe administration of the measles vaccine to children allergic to eggs. James JM; Burks AW; Roberson PK; Sampson HA N Engl J Med; 1995 May; 332(19):1262-6. PubMed ID: 7708070 [TBL] [Abstract][Full Text] [Related]